Global Oral Drug Delivery Market Growth 2025-2031

Global Oral Drug Delivery Market Growth 2025-2031

The global Oral Drug Delivery market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Oral drug delivery is the most preferred administration route due to noninvasive, high patient compliance, convenient to handle, and does not require any specific sterile conditions. However, some of the drugs administered orally face several physical, biological, and biochemical barriers which lower the therapeutic efficacy of the drugs before getting absorbed into the systemic circulation. The utilization of nanocarriers for oral drug delivery overcome abovementioned barriers and considered as an alternative strategy to address the drawbacks of oral drug delivery. In this chapter, the recent advancement of nanocarriers in oral drug delivery application for the treatment of various diseases is summarized. Furthermore, the chapter explains how different nanocarriers designing technology enhance the therapeutic potential to overcome the various barriers such as physical, biological, and biochemical. Although, in recent years, several nanocarrier-based drug delivery technologies have been evolved and showing promising results but still it is far from the real utilization in the clinic.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the “Oral Drug Delivery Industry Forecast” looks at past sales and reviews total world Oral Drug Delivery sales in 2024, providing a comprehensive analysis by region and market sector of projected Oral Drug Delivery sales for 2025 through 2031. With Oral Drug Delivery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Drug Delivery industry.

This Insight Report provides a comprehensive analysis of the global Oral Drug Delivery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Drug Delivery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Drug Delivery market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Drug Delivery and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Drug Delivery.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Drug Delivery market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Diffusion Controlled Release System
Dissolution Controlled Release System
Ion Exchange Resins Controlled Release
Hydro-dynamically Balanced Drug Delivery System
Osmotically Controlled Release System
Dissolution & Diffusion Controlled Release System

Segmentation by Application:
Hospitals
Clinics
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
AstraZeneca Plc.
Mylan N.V.
Sanofi
F. Hoffman-La-Roche Ltd.
Bristol-Myers Squibb Company
Sun Pharmaceuticals Industries Ltd
Abbott Laboratories
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Vectura Group plc.
GlaxoSmithKline plc.
Johnson & Johnson Services, Inc

Key Questions Addressed in this Report

What is the 10-year outlook for the global Oral Drug Delivery market?

What factors are driving Oral Drug Delivery market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Oral Drug Delivery market opportunities vary by end market size?

How does Oral Drug Delivery break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.